CareDx Inc
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution … Read more
CareDx Inc (CDNA) - Total Liabilities
Latest total liabilities as of September 2025: $121.17 Million USD
Based on the latest financial reports, CareDx Inc (CDNA) has total liabilities worth $121.17 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CareDx Inc - Total Liabilities Trend (2012–2024)
This chart illustrates how CareDx Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CareDx Inc Competitors by Total Liabilities
The table below lists competitors of CareDx Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SIMMTECH Co. Ltd
KQ:222800
|
Korea | ₩1.01 Trillion |
|
Gujarat State Petronet Limited
NSE:GSPL
|
India | ₹59.77 Billion |
|
Hiconics Drive Tech Co
SHE:300048
|
China | CN¥3.06 Billion |
|
Sino Wealth Electronic Ltd
SHE:300327
|
China | CN¥406.94 Million |
|
Corporación Interamericana de Entretenimiento S.A.B. de C.V
MX:CIEB
|
Mexico | MX$7.70 Billion |
|
Teemsun Technology Co.,Ltd
SHE:301571
|
China | CN¥1.05 Billion |
|
Raven Industries Inc
F:RV1
|
Germany | €5.93 Billion |
|
Bajaj Housing Finance
NSE:BAJAJHFL
|
India | ₹947.96 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down CareDx Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CareDx Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CareDx Inc (2012–2024)
The table below shows the annual total liabilities of CareDx Inc from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $112.62 Million | -45.20% |
| 2023-12-31 | $205.50 Million | +83.35% |
| 2022-12-31 | $112.08 Million | +11.25% |
| 2021-12-31 | $100.75 Million | +10.91% |
| 2020-12-31 | $90.83 Million | +72.24% |
| 2019-12-31 | $52.74 Million | +51.68% |
| 2018-12-31 | $34.77 Million | -61.16% |
| 2017-12-31 | $89.52 Million | +57.14% |
| 2016-12-31 | $56.97 Million | +117.90% |
| 2015-12-31 | $26.14 Million | +31.75% |
| 2014-12-31 | $19.84 Million | -87.64% |
| 2013-12-31 | $160.55 Million | +2.21% |
| 2012-12-31 | $157.08 Million | -- |